VYNE Therapeutics Inc. - COM (VYNE)

Historical Portfolio Holders from Q1 2021 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
36.5K
Holdings value Q2 2024
$71.9K
Value change Q2 2024
+$31.00
Grand Portfolio weight change Q2 2024
0%
Number of holders
2
Number of buys Q2 2024
1
Number of sells Q2 2024
-1
Average buys Q2 2024 %
0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 36.5K $71.9K +$31.00 $1.96 2
2024 Q1 36.5K $112K +$6.00 $3.04 2
2023 Q4 36.5K $85K +$30.3K $2.33 1
2023 Q3 23.5K $94.8K $0 $4.04 1
2023 Q2 23.5K $96.2K $0 $4.10 1
2023 Q1 23.5K $72K -$1.21M $3.07 1
2022 Q4 7.32M $1.1M -$144K $0.15 36
2022 Q3 8.24M $1.84M -$65.7K $0.22 28
2022 Q2 8.36M $3.25M -$274K $0.39 33
2022 Q1 8.65M $5.62M -$3.32M $0.65 35
2021 Q4 12.3M $12.5M -$2.3M $1.02 44
2021 Q3 14.5M $20.1M -$6.72M $1.39 55
2021 Q2 18.2M $64M -$17.3M $3.51 65
2021 Q1 22.3M $152M +$152M $6.84 84